Dr. Chakradhar Madhavareddigari Reddy, MD

Dr. Reddy practices at Endoscopy Center of Northeast Tennessee in Johnson City, Tennessee.

Dr. Reddy's NPI, 1548360332, was assigned on September 22, 2006. Dr. Reddy holds Tennessee license 46923.

Dr. Reddy's primary practice is Endoscopy Center of Northeast Tennessee, at 310 State Of North Franklin Road, Suite 202, Johnson City, TN 37604. The practice phone is (423) 929-7111.

Dr. Reddy's primary practice is Endoscopy Center of Northeast Tennessee in Johnson City, Tennessee. Dr. Reddy is also affiliated with Johnson City Medical Center. The medical group on file is Gastrointestinal Associates of Northeast Tennessee. Dmand AI also links Dr. Reddy to 4 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Reddy practices, 6 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Reddy's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Reddy is licensed in Tennessee.

CMS data shows 839 Medicare services from Dr. Reddy across 15 procedure codes in 2024, for 523 Medicare patients. Medicare paid $79,463 for them.

CMS counts 523 Medicare patients who saw Dr. Reddy in 2024. The largest group is 65 to 74, with 284 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 12% are also on Medicaid. Their average risk score is 1.67, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Reddy's median patient age at 61, with 59% women.

In 2024, Dr. Reddy wrote 993 Medicare Part D claims for 539 patients. 79% of them were for generic drugs. CMS names the drug for 801 of them, across 18 drugs with 11 or more claims each, at $125,711 in total drug cost. In 2023, CMS named 879 claims across 20 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Reddy for performance year 2024, reported as part of a group. Dr. Reddy accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 180 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Reddy, more than 88% of the clinicians it reports for that procedure.

Dmand AI links Dr. Reddy to 3 clinical trials, 2 of them phase 3 studies. Conditions studied include Non-alcoholic Fatty Liver Disease, Fatty Liver and Eosinophilic Esophagitis. Intercept Pharmaceuticals sponsors the most, 2. Open Payments lists research payments to Dr. Reddy that name 3 trials.

CMS Open Payments shows 637 general payments to Dr. Reddy from 33 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 79% of the total. Gilead Sciences, Inc. paid the most, $197,102. It also lists 92 research payments totaling $365,788 from 2019 to 2024, naming 3 clinical trials.